Kenneth Blum

15.9k total citations · 1 hit paper
420 papers, 9.6k citations indexed

About

Kenneth Blum is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Kenneth Blum has authored 420 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Cellular and Molecular Neuroscience, 113 papers in Psychiatry and Mental health and 77 papers in Pharmacology. Recurrent topics in Kenneth Blum's work include Neurotransmitter Receptor Influence on Behavior (169 papers), Attention Deficit Hyperactivity Disorder (95 papers) and Receptor Mechanisms and Signaling (42 papers). Kenneth Blum is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (169 papers), Attention Deficit Hyperactivity Disorder (95 papers) and Receptor Mechanisms and Signaling (42 papers). Kenneth Blum collaborates with scholars based in United States, Hungary and Israel. Kenneth Blum's co-authors include David E. Comings, Eric R. Braverman, Mark S. Gold, Jack Wallace, Thomas J.H. Chen, Marlene Oscar‐Berman, Rajendra D. Badgaiyan, Murray G. Hamilton, Irving Geller and Joel F. Lubar and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Kenneth Blum

404 papers receiving 9.1k citations

Hit Papers

The Reward Deficiency Syndrome: A Biogenetic Model for th... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth Blum United States 45 4.3k 2.5k 1.8k 1.7k 1.7k 420 9.6k
Undine E. Lang Switzerland 54 4.1k 0.9× 2.2k 0.9× 2.6k 1.4× 1.7k 1.0× 2.9k 1.7× 377 17.4k
Michael J. Owens United States 52 3.3k 0.8× 1.2k 0.5× 1.4k 0.8× 1.3k 0.8× 1.9k 1.1× 164 11.2k
Lars Oreland Sweden 61 5.1k 1.2× 1.9k 0.7× 3.0k 1.6× 1.2k 0.7× 3.1k 1.9× 346 13.5k
Christopher Wong United States 52 5.3k 1.2× 2.7k 1.1× 2.4k 1.3× 1.2k 0.7× 1.7k 1.0× 91 12.2k
Hiroshi Kunugi Japan 66 3.3k 0.8× 2.9k 1.2× 1.6k 0.8× 1.0k 0.6× 4.2k 2.5× 446 15.7k
J. John Mann United States 69 3.6k 0.8× 3.2k 1.3× 5.2k 2.8× 1.7k 1.0× 2.3k 1.4× 208 14.3k
Astrid Nehlig France 55 4.8k 1.1× 2.9k 1.2× 787 0.4× 2.5k 1.5× 2.4k 1.5× 231 11.9k
Glen B. Baker Canada 62 4.8k 1.1× 1.8k 0.7× 966 0.5× 2.1k 1.2× 3.3k 2.0× 430 13.6k
Shigenobu Kanba Japan 64 2.0k 0.5× 3.4k 1.4× 2.7k 1.5× 932 0.6× 1.8k 1.1× 324 14.1k
Simon N. Young Canada 57 2.6k 0.6× 1.4k 0.6× 1.9k 1.1× 880 0.5× 1.0k 0.6× 229 9.4k

Countries citing papers authored by Kenneth Blum

Since Specialization
Citations

This map shows the geographic impact of Kenneth Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Blum more than expected).

Fields of papers citing papers by Kenneth Blum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Blum. The network helps show where Kenneth Blum may publish in the future.

Co-authorship network of co-authors of Kenneth Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Blum. A scholar is included among the top collaborators of Kenneth Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Blum. Kenneth Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blum, Kenneth, David Baron, Kai‐Uwe Lewandrowski, et al.. (2025). Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social Behavior. Journal of Integrative Neuroscience. 24(6). 36646–36646. 1 indexed citations
2.
Modestino, Edward J., Abdalla Bowirrat, Kai‐Uwe Lewandrowski, et al.. (2024). Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss. PubMed. 7(5). 12–18.
3.
Alvarenga, Regina Maria Papais, Plínio Santos Ramos, Kenneth Blum, et al.. (2024). Assessing the Impact of IL-6 and Serotonin on Pain and Symptomatology in Fibromyalgia: An Exploratory Clinical Study. Journal of Personalized Medicine. 14(8). 886–886. 5 indexed citations
4.
Samanta, Saptadip, et al.. (2024). A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD). Psychology Research and Behavior Management. Volume 17. 3485–3501. 1 indexed citations
6.
Blum, Kenneth, Thomas McLaughlin, Mark S. Gold, et al.. (2023). Are We Getting High Cause the Thrill is Gone?. PubMed. 7(1). 5–516. 1 indexed citations
7.
Blum, Kenneth, Paul R. Carney, Panayotis K. Thanos, et al.. (2023). Psychostimulants for Children: Are We Over or Under Dosing?. PubMed. 7(1). 1–4.
8.
Blum, Kenneth, Igor Elman, Abdalla Bowirrat, et al.. (2022). Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of Personalized Medicine. 12(10). 1719–1719. 10 indexed citations
9.
Blum, Kenneth, Thomas McLaughlin, Abdalla Bowirrat, et al.. (2022). Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”?. Journal of Personalized Medicine. 12(2). 321–321. 23 indexed citations
10.
Modestino, Edward J., Kenneth Blum, Debasis Bagchi, et al.. (2022). Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing. Journal of Personalized Medicine. 12(12). 1946–1946. 11 indexed citations
11.
Blum, Kenneth, Abdalla Bowirrat, Jag Khalsa, et al.. (2022). Neurogenetic and Epigenetic Aspects of Cannabinoids. Epigenomes. 6(3). 27–27. 8 indexed citations
12.
Braverman, Eric R., Mark S. Gold, Abdalla Bowirrat, et al.. (2022). Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”. International Journal of Environmental Research and Public Health. 19(9). 5480–5480. 7 indexed citations
13.
Madigan, Margaret, Ashim Gupta, Abdalla Bowirrat, et al.. (2022). Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?. International Journal of Environmental Research and Public Health. 19(11). 6395–6395. 5 indexed citations
14.
Barh, Debmalya, Sandeep Tiwari, Bruno Silva Andrade, et al.. (2021). A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19. Molecular Omics. 17(2). 317–337. 21 indexed citations
15.
Blum, Kenneth, Abdalla Bowirrat, Eric R. Braverman, et al.. (2021). Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International Journal of Environmental Research and Public Health. 18(21). 11529–11529. 15 indexed citations
16.
Blum, Kenneth, David Baron, Lisa Lott, et al.. (2019). In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing. PubMed. 9(1). 7–21. 20 indexed citations
17.
Febo, Marcelo, Kenneth Blum, Rajendra D. Badgaiyan, et al.. (2017). Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS ONE. 12(4). e0174774–e0174774. 48 indexed citations
19.
Blum, Kenneth, William H. Frey, Shoji Tsuji, et al.. (2015). Proceedings of the First Neurological Disorders Summit (NDS-2015). 1 indexed citations
20.
Blum, Kenneth, David K. Han, Marlene Oscar‐Berman, et al.. (2013). Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs. Health. 5(11). 16–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026